Chlortalidone/Telmisartan

Drug Profile

Chlortalidone/Telmisartan

Alternative Names: Chlorthalidone/telmisartan; HL-063B; Telmisartan/chlortalidone; Telmisartan/Chlorthalidone

Latest Information Update: 19 Aug 2015

$50 / €47 *
* $ price applies to USA, Canada and Latin America. € price applies to the rest of the world. Final gross prices may vary according to local VAT.

At a glance

  • Originator HanAll Biopharma
  • Class Antihypertensives; Benzimidazoles; Benzoates; Small molecules; Sulfonamides; Thiazides
  • Mechanism of Action ACE inhibitors; Angiotensin type 1 receptor antagonists; Thiazide-like diuretics
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase III Hypertension

Most Recent Events

  • 01 Aug 2015 Phase-III clinical trials in Hypertension in South Korea (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top